Corporate Disclosure2026-05-06
SAMIK PHARM CO.,LTD Value Plan
삼익제
삼익제약
014950
Signal Score
50C — Neutral
Score50 / 100
Historical Avg Return (5d)
+0.05%
Data Coverage
100%n=9478
Risk-adjusted indicator based on 9478 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
POSITIVE
Key Numbers
- • Revenue Target by 2030: 1,300,000,000 KRW
- • Operating Profit Target by 2030: 110,000,000 KRW
3 more figures — unlock with API access
AI Analysis Summary
Developer & Pro plans
Risk Factors
Developer & Pro plans
Access Full Korean Market Signal Analytics
✔ AI-parsed DART filing classification & scoring
✔ Real-time event impact indicators
✔ Historical pattern data via REST API
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.
AI-processed analysis. Based on: 기업가치제고계획(자율공시) (2026년 삼익제약(주) 기업가치 제고 계획). Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.